Search Results 111-120 of 22527 for oral

  1. Relugolix (oral route) - Mayo Clinic

    For oral dosage form (tablets):. For treatment of advanced prostate cancer: Adults—At first, 360 milligrams (mg) once on the first day, then 120 mg once a ...

  2. Papaverine (oral route) - Mayo Clinic

    For oral dosage form (tablets):. Adults: 100 to 300 milligrams (mg) three to five times a day. Missed Dose.

  3. Flibanserin (oral route) - Mayo Clinic

    For oral dosage form (tablets):. For treatment of hypoactive sexual desire disorder: Adults—100 milligrams (mg) once a day at bedtime. Children—Use is not ...

  4. Pramipexole (oral route) - Mayo Clinic

    For oral dosage form (extended-release tablets):. For Parkinson disease: Adults—At first, 0.375 milligram (mg) once a day. Your doctor may adjust your dose as ...

  5. Balsalazide (oral route) - Mayo Clinic

    For treatment of ulcerative colitis: For oral dosage form (capsules):. Adults—2.25 grams (g) (3 capsules) 3 times a day for 8 weeks.

  6. Mebendazole (oral route) - Mayo Clinic

    Dosing · For oral dosage form (Emverm™ chewable tablets):. For common roundworms, hookworms, and whipworms: Adults and children 2 years of age and older—100 ...

  7. Curriculum - Oral and Maxillofacial Surgery Residency, M.D.-O.M.S. (Minnesota) - Mayo Clinic College of Medicine & Science

    Curriculum for the Oral and Maxillofacial Surgery Residency at Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.

  8. Piroxicam (oral route) - Mayo Clinic

    For oral dosage form (capsules):. For osteoarthritis and rheumatoid arthritis: Adults—20 milligrams (mg) once a day or 10 mg 2 times a day. Children—Use and ...

  9. Paricalcitol (oral route) - Mayo Clinic

    For oral dosage form (capsules):. For hyperparathyroidism in patients with chronic kidney disease: Adults—At first, 1 to 2 micrograms (mcg) once a day or 2 ...

  10. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    Also approved for the treatment of rheumatoid arthritis in the U.S., tofacitinib is a selective Janus kinase (JAK) inhibitor and the first oral medication ...